Jan 11, 2022 / 03:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Elanco this morning at the 40th Annual JPMorgan Healthcare Conference. From the company, we have Jeff Simmons, President and CEO. Before I turn it over to Jeff, I want to remind folks that to ask a question.
please feel free to use the ask a question feature on the website, and I'll work those into the Q&A post the presentation. With that, Jeff, Happy New Year. Thanks for joining us and looking forward to the presentation.
Jeffrey N. Simmons - Elanco Animal Health Incorporated - President, CEO & Director
Thanks, Chris. Happy New Year to you. Thank you to JPMorgan and to everyone for the work you do in covering Aanimal Hhealth, and we appreciate the opportunity to engage with you and our investors here over the next couple of days.
First of all, I'll ask you, as always, just to reference the disclaimer on Slide 2 of the deck that we put out. Today's
Elanco Animal Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot